相关实验视频
Updated: Sep 16, 2025

08:35
Inducible and Reversible Dominant-negative DN Protein Inhibition
Published on: January 7, 2019
8.5K
通过PAX5::CBFA2T3对PAX5转录活性进行双向抑制
Reina Ueno1, Aki Terasaki1, Yuiko Imai1
1Division of Cellular and Genetic Sciences, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Japan.
FEBS open bio
|July 11, 2025
概括
B细胞急性淋巴细胞白血病中PAX5::CBFA2T3融合蛋白通过两个不同的机制抑制PAX5基因活性:DNA结合和HDAC招募. 这为B-ALL病原体提供了新的见解.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- PAX5对于B细胞分化至关重要,激活特定的基因.
- 涉及PAX5的染色体重组发生在2-3%的B细胞急性淋巴细胞白血病 (B-ALL) 病例中.
- 这些重新排列通常会导致编码嵌合蛋白的融合转录.
研究的目的:
- 研究PAX5::CBFA2T3 (PAX5-C) 融合蛋白对PAX5转录活性的功能影响.
- 阐明PAX5-C抑制PAX5功能在B-ALL中的机制.
主要方法:
- 路西法酶试验被用来测量PAX5的转录活性.
- 同免疫沉测定确定了PAX5-C的结合伙伴,包括HDAC1/3.3.
- 染色体免疫沉后进行定量PCR (ChIP-qPCR) 评估促进体结合.
- 实验涉及野生类型和DNA结合缺陷的PAX5-C突变,以及HDAC抑制/敲击.
主要成果:
- PAX5-C强烈抑制了PAX5的转录活动.
- PAX5-C与PAX5和HDAC1/3.3相互作用
- 抑制通过两个足够的机制发生:依赖DNA结合和依赖HDAC.
- 依赖DNA结合的抑制涉及PAX5-C.的促进体占用.
- 在HDAC依赖的抑制中,HDAC1/3被调入PAX5转录复合体.
结论:
- PAX5-C利用双重机制来抑制PAX5的功能,有助于B-ALL的发展.
- 了解这些抑制机制为在白血病中PAX5-融合蛋白活性提供了新的见解.
- 这些发现突出了涉及PAX5重组的B-ALL的潜在治疗点.
相关概念视频
Combinatorial Gene Control
8.4K
Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
8.4K
Master Transcription Regulators
7.1K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.1K
Cooperative Binding of Transcription Regulators
2.1K
2.1K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Eukaryotic Transcription Inhibitors
10.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.0K

